Cargando…
Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016
Infectious complications after allogeneic haematopoietic stem cell transplantation (allo-HCT) remain a clinical challenge. This is a guideline provided by the AGIHO (Infectious Diseases Working Group) of the DGHO (German Society for Hematology and Medical Oncology). A core group of experts prepared...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972852/ https://www.ncbi.nlm.nih.gov/pubmed/27339055 http://dx.doi.org/10.1007/s00277-016-2711-1 |
_version_ | 1782446303932841984 |
---|---|
author | Ullmann, Andrew J. Schmidt-Hieber, Martin Bertz, Hartmut Heinz, Werner J. Kiehl, Michael Krüger, William Mousset, Sabine Neuburger, Stefan Neumann, Silke Penack, Olaf Silling, Gerda Vehreschild, Jörg Janne Einsele, Hermann Maschmeyer, Georg |
author_facet | Ullmann, Andrew J. Schmidt-Hieber, Martin Bertz, Hartmut Heinz, Werner J. Kiehl, Michael Krüger, William Mousset, Sabine Neuburger, Stefan Neumann, Silke Penack, Olaf Silling, Gerda Vehreschild, Jörg Janne Einsele, Hermann Maschmeyer, Georg |
author_sort | Ullmann, Andrew J. |
collection | PubMed |
description | Infectious complications after allogeneic haematopoietic stem cell transplantation (allo-HCT) remain a clinical challenge. This is a guideline provided by the AGIHO (Infectious Diseases Working Group) of the DGHO (German Society for Hematology and Medical Oncology). A core group of experts prepared a preliminary guideline, which was discussed, reviewed, and approved by the entire working group. The guideline provides clinical recommendations for the preventive management including prophylactic treatment of viral, bacterial, parasitic, and fungal diseases. The guideline focuses on antimicrobial agents but includes recommendations on the use of vaccinations. This is the updated version of the AGHIO guideline in the field of allogeneic haematopoietic stem cell transplantation utilizing methods according to evidence-based medicine criteria. |
format | Online Article Text |
id | pubmed-4972852 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-49728522016-08-17 Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016 Ullmann, Andrew J. Schmidt-Hieber, Martin Bertz, Hartmut Heinz, Werner J. Kiehl, Michael Krüger, William Mousset, Sabine Neuburger, Stefan Neumann, Silke Penack, Olaf Silling, Gerda Vehreschild, Jörg Janne Einsele, Hermann Maschmeyer, Georg Ann Hematol Original Article Infectious complications after allogeneic haematopoietic stem cell transplantation (allo-HCT) remain a clinical challenge. This is a guideline provided by the AGIHO (Infectious Diseases Working Group) of the DGHO (German Society for Hematology and Medical Oncology). A core group of experts prepared a preliminary guideline, which was discussed, reviewed, and approved by the entire working group. The guideline provides clinical recommendations for the preventive management including prophylactic treatment of viral, bacterial, parasitic, and fungal diseases. The guideline focuses on antimicrobial agents but includes recommendations on the use of vaccinations. This is the updated version of the AGHIO guideline in the field of allogeneic haematopoietic stem cell transplantation utilizing methods according to evidence-based medicine criteria. Springer Berlin Heidelberg 2016-06-24 2016 /pmc/articles/PMC4972852/ /pubmed/27339055 http://dx.doi.org/10.1007/s00277-016-2711-1 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Ullmann, Andrew J. Schmidt-Hieber, Martin Bertz, Hartmut Heinz, Werner J. Kiehl, Michael Krüger, William Mousset, Sabine Neuburger, Stefan Neumann, Silke Penack, Olaf Silling, Gerda Vehreschild, Jörg Janne Einsele, Hermann Maschmeyer, Georg Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016 |
title | Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016 |
title_full | Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016 |
title_fullStr | Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016 |
title_full_unstemmed | Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016 |
title_short | Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016 |
title_sort | infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016 |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972852/ https://www.ncbi.nlm.nih.gov/pubmed/27339055 http://dx.doi.org/10.1007/s00277-016-2711-1 |
work_keys_str_mv | AT ullmannandrewj infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016 AT schmidthiebermartin infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016 AT bertzhartmut infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016 AT heinzwernerj infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016 AT kiehlmichael infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016 AT krugerwilliam infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016 AT moussetsabine infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016 AT neuburgerstefan infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016 AT neumannsilke infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016 AT penackolaf infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016 AT sillinggerda infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016 AT vehreschildjorgjanne infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016 AT einselehermann infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016 AT maschmeyergeorg infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016 AT infectiousdiseasesinallogeneichaematopoieticstemcelltransplantationpreventionandprophylaxisstrategyguidelines2016 |